NO940131L - Salter av 4-pyrimidinon-derivater for farmasöytisk anvendelse - Google Patents

Salter av 4-pyrimidinon-derivater for farmasöytisk anvendelse

Info

Publication number
NO940131L
NO940131L NO940131A NO940131A NO940131L NO 940131 L NO940131 L NO 940131L NO 940131 A NO940131 A NO 940131A NO 940131 A NO940131 A NO 940131A NO 940131 L NO940131 L NO 940131L
Authority
NO
Norway
Prior art keywords
salts
pharmaceutical use
pyrimidinone derivatives
derivatives
pyrimidinone
Prior art date
Application number
NO940131A
Other languages
English (en)
Other versions
NO940131D0 (no
Inventor
Christian Hoornaert
Alexander Eduard Wick
Original Assignee
Synthelabo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Synthelabo filed Critical Synthelabo
Publication of NO940131D0 publication Critical patent/NO940131D0/no
Publication of NO940131L publication Critical patent/NO940131L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/32—One oxygen, sulfur or nitrogen atom
    • C07D239/34—One oxygen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/10—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing aromatic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Ophthalmology & Optometry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

Alkanolaminsalter og basiske aminosyresalter av fire pyrimidi-nonderivater som kan foreligge i form av tautornerer med formel (I) , (I') og (I" ). hvori. Rx står for en rettkjedet eller forgrenet (C-C,)alkylgruppe,. Rstår enten for en aryl (C^-Cj) alkylgruppe som eventuelt er substituert på kjernen, eller en heteroaryl(C-C)alkylgruppe som eventuelt er substituert på kjernen, og. Rstår enten for en COOH-gruppe, eller en lH-tetrazol-5-yl-gruppe.Derivatene har terapeutisk anvendelse. Deres fremstilling er beskrevet.
NO940131A 1993-01-15 1994-01-14 Salter av 4-pyrimidinon-derivater for farmasöytisk anvendelse NO940131L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9300340A FR2700543B1 (fr) 1993-01-15 1993-01-15 Sels de dérivés de 4-pyrimidinone, leur préparation et leur application en thérapeutique.

Publications (2)

Publication Number Publication Date
NO940131D0 NO940131D0 (no) 1994-01-14
NO940131L true NO940131L (no) 1994-07-18

Family

ID=9443056

Family Applications (1)

Application Number Title Priority Date Filing Date
NO940131A NO940131L (no) 1993-01-15 1994-01-14 Salter av 4-pyrimidinon-derivater for farmasöytisk anvendelse

Country Status (16)

Country Link
EP (1) EP0607077A1 (no)
JP (1) JPH06271548A (no)
KR (1) KR940018365A (no)
CN (1) CN1096783A (no)
AU (1) AU5317694A (no)
CA (1) CA2113491A1 (no)
CZ (1) CZ9494A3 (no)
FI (1) FI940185A (no)
FR (1) FR2700543B1 (no)
HU (1) HUT70193A (no)
IL (1) IL108342A0 (no)
NO (1) NO940131L (no)
NZ (1) NZ250678A (no)
PL (1) PL301900A1 (no)
SK (1) SK4794A3 (no)
ZA (1) ZA94290B (no)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR19990081093A (ko) * 1998-04-25 1999-11-15 조생현 피리미디논 화합물, 이를 함유하는 약제학적 조성물 및 이의제조방법
GB0914287D0 (en) * 2009-08-14 2009-09-30 Pci Biotech As Compositions

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2672892B1 (fr) * 1991-02-20 1994-01-14 Synthelabo Derives de 4-pyrimidinones, leur preparation et leur application en therapeutique.

Also Published As

Publication number Publication date
JPH06271548A (ja) 1994-09-27
HU9400108D0 (en) 1994-05-30
FI940185A (fi) 1994-07-16
AU5317694A (en) 1994-07-21
FR2700543B1 (fr) 1995-03-17
EP0607077A1 (fr) 1994-07-20
IL108342A0 (en) 1994-04-12
NO940131D0 (no) 1994-01-14
CN1096783A (zh) 1994-12-28
KR940018365A (ko) 1994-08-16
PL301900A1 (en) 1994-07-25
FR2700543A1 (fr) 1994-07-22
SK4794A3 (en) 1995-01-12
HUT70193A (en) 1995-09-28
CZ9494A3 (en) 1994-08-17
FI940185A0 (fi) 1994-01-14
NZ250678A (en) 1994-10-26
CA2113491A1 (en) 1994-07-16
ZA94290B (en) 1994-08-17

Similar Documents

Publication Publication Date Title
CA2379560A1 (en) Purine derivatives inhibitors of tyrosine protein kinase syk
HUP0004559A1 (hu) Ciklinfüggő kinázok aminotiazol inhibitorai, az ezeket tartalmazó gyógyszerkészítmények és alkalmazásuk
NO930511D0 (no) Orto-substituerte benzoylguanidiner, fremgangsmaater for fremstillling av dem, deres anvendelse som diagnostikum saavel som medikamenter som inneholder dem
NO995006L (no) Nye forbindelser
CA2030433A1 (en) New isoquinoline- carboxamide amino acid derivatives useful for treatment of viral diseases
FI900085A0 (fi) Menetelmä terapeuttisesti käyttökelpoisten N-(pyrimidin- ja kondensoitu pyrimidin-4-oni)etyyli-piperidiini- ja piperatsiinijohdannaisten valmistamiseksi
NO941611D0 (no) Nye aminosyrederivater, fremgangsmåte for deres fremstilling og farmasöytiske preparater inneholdende disse forbindelser
NO922940L (no) Fem-leddete heterocykliske forbindelser, fremgangsmaate for deres fremstilling og legemidler inneholdende dem
MXPA01004256A (es) N-arilamidas del acido antranilico y del acido tioantranilico.
NO176356C (no) Analogifremgangsmåte for fremstilling av nye terapeutisk aktive pyrazolopyridinforbindelser
NO881940L (no) 4-aminokinolin-derivater og deres anvendelse som legemidler.
NO933248L (no) Cykliske urinstoffderivater, legemidler inneholdende disse forbindelser, og fremgangsmåte for deres fremstilling
NO934501L (no) Karboksylsyrederivater, legemidler inneholdende disse forbindelser, og fremgangsmåte for deres fremstilling
WO1998056761A3 (en) Benzimidazole derivatives
ES2121760T3 (es) Compuesto de pirazolopiridina y procedimiento para su preparacion.
NO903438D0 (no) Fremgangsmaate for fremstilling av tiazolderivater.
NO331002B1 (no) Tioxantinderivater og farmasoytiske preparater med tioxantinderivater
DK159444C (da) Analogifremgangsmaade til fremstilling af derivater af 9-(2-hydroxyethoxymethyl)guanin
NO971625L (no) Nye peptider med immunomodulatoriske effekter
NO20016201L (no) Tienopyrimidiner som fosfodiesteraseinhibitorer
ATE361918T1 (de) 4-(4-methoxybenzyl)-n'-(5-nitro-1,3-thiazol-2- yl)harnstoff und dessen verwendung bei der behandlung von mit glycogensynthasekinase-3 (gsk3) assoziierten leiden
NO20022123L (no) Osoksazolderivater for anvendelse som inhibitorer for fosfodiesterase VII
FI882002A (fi) Menetelmä terapeuttisesti aktiivisten fenyylipiperidiinijohdannaisten valmistamiseksi
DK0634396T3 (da) Aminosyrederivater og deres anvendelse som enkeltfalinaseinhibitorer
HUT45081A (en) Process for producing amino acid derivatives and pharmaceuticals comprising these compounds as active ingredient